Navigation Links
Study Says Using the da Vinci Surgical Robot for a Hysterectomy Fails to Cut Complications and May Raise Pneumonia Risk, Notes Parker Waichman LLP
Date:9/11/2013

New York, NY (PRWEB) September 11, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that a Sept. 10 Bloomberg report details a study that reveals using the da Vinci surgical robot to perform a hysterectomy doesn’t reduce complications and could possibly raise the risk of pneumonia when compared with the use of conventional surgical techniques. For the study, researchers examined data from about 16,000 women who had hysterectomies for benign conditions in 2009 and 2010, Bloomberg added.

Operations performed with the da Vinci surgical robot cost hospitals $2,489 more per procedure but have a similar complication rate when compared with the standard practice of removing the uterus with minimally invasive equipment, according to the study, as Bloomberg reported. “Unfortunately, the greater costs associated with robotic-assisted hysterectomy were not reflected in improvement in outcomes,” researchers at the University of Texas Southwestern Medical Center at Dallas, who conducted the study, told Bloomberg.

The increased risk of pneumonia finding could be due to the large number of robotic hysterectomy patients who need intubation after their operation, Bloomberg reported. During robotic hysterectomies, patients are positioned at a steep angle, with their heads down. This could cause fluid to build up in the airways, Bloomberg reported the study as suggesting.

The da Vinci surgical robot’s safety and cost effectiveness have been under scrutiny, according to a July 19 Bloomberg report. In February, U.S. regulators started surveying surgeons about the robots following a rise in adverse event reports that included as many as 70 deaths since 2009. In that same report, Bloomberg noted that the U.S. Food and Drug Administration (FDA) sent a warning letter on July 17 to Intuitive Surgical after inspections in April and May by the agency found some problems, including the company’s failure to adequately report device corrections and patient adverse events.

Bloomberg also noted in the report that the da Vinci surgical robot, which is used in more than 1,300 hospitals, has been the subject of negligence lawsuits alleging that patients were injured during surgeries with the device. Cancer surgery, hysterectomies and gall bladder removals are among the main procedures performed with da Vinci surgical robot, the report added.

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by the da Vinci surgical robot. If you or a loved one experienced surgical burns, perforated or torn organs, torn blood vessels or other injuries that could be associated with the da Vinci surgical robot, please contact their office by visiting the firm's da Vinci Surgical Robot Lawsuit page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+(800) LAW-INFO
1+(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/da_vinci_study/09/prweb11110666.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Examining Risks and Benefits of Robotic Surgery Hysterectomy
2. American families taking divergent paths, study finds
3. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on New Study Findings that Casts Doubt on Robot-Assisted Hysterectomy
4. Study: Redefining the Criteria for ALK Positive Lung Cancer
5. Study: Redefining the criteria for ALK positive lung cancer
6. UCI-led study creates new memories by directly changing the brain
7. Study identifies fibroblast growth factor 18 as an ovarian cancer biomarker
8. Study Indicates Benefits of Stem Cells in Treating MS Declines With Donor’s Age
9. Study uncovers value of mammogram screening for younger women
10. ACR, SBI on cancer study: More breast cancer screening needed in younger women
11. MERS-CoV treatment effective in monkeys, NIH study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... Advanced Spine & ... cells” and Platelet Rich Plasma (PRP) injections. “These are becoming the ‘go-to’ treatment ... D.C., of Advanced Spine & Sport Medical. “We are very excited to be ...
(Date:5/1/2016)... Santa Rosa, CA (PRWEB) , ... May 01, 2016 , ... ... pioneer in the medical marijuana industry, has put the law in the hands ... cannabis. On January 1, 2016, California voted to allow counties to vote on ...
(Date:4/30/2016)... ... April 30, 2016 , ... The ... , a program to critically evaluate and rank health-focused applications and connected devices ... to provide independent, unbiased and accurate information to help accelerate patient and provider ...
(Date:4/30/2016)... Indianapolis, Indiana (PRWEB) , ... April 30, 2016 , ... ... USA Wrestling as they go for gold in Rio. Under the care of ... including two golds! , In an unprecedented showing, Maximized Living is sending the largest ...
(Date:4/29/2016)... ... April 29, 2016 , ... Memorial ... for Graduate Medical Education (ACGME) that it has received accreditation for its residency ... of three residency programs that Memorial is currently pursuing, including Pediatrics and Internal ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... consumer insights on healthcare, announced today that it has ... report Cool Vendor in Life Sciences, 2016, ... 15, 2016.  The report focuses on life-science- oriented analytics, ... insight from patients and doctors, confirm medication ingestion, and ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage ... gene-based immunotherapeutics and vaccines for the treatment of cancer & ... 3rd Annual Growth Capital Expo to be held ... Caesars Palace in Las Vegas, Nevada.  The Company presentation ... th by Dr. John N. Bonfiglio a ...
Breaking Medicine Technology: